Back to the main directory
EarningsReview / Equity
- Rejlers - Pricing in focus for 2022 by Danske Bank Equity Research
- A challenging environment by BNP Paribas Exane
- Kesko - Sell/EUR 25.10 (23.80): Upbeat but wide 2022 EBIT guidance range by Nordea
- Solid, but upgrades from here limited by BNP Paribas Exane
- INVEST SECURITIES_GECINA: Vers un asset management plus positif pour le résultat_ NEUTRE, OC 123€ (vs 120€) by Invest Securities
- Investment Daily 04/02/2022 by BNP Paribas Exane
- A solid 2021, but license dependency creates 2022 risk by BNP Paribas Exane
- VINCI: RDOS. 2021 (ANÁLISIS BANCO SABADELL) by Sabadell
- Nordnet - A strong quarter but focus on upcoming CMD by Danske Bank Equity Research
- SKF - Poor execution by Danske Bank Equity Research
- Basware - Buy/EUR 35 (45): Risk/reward worth a look despite estimate cuts by Nordea
- Bonava - Buy/SEK 135: Long-term story intact by Nordea
- Kinnevik - Hold: Risk of weaker venture capital markets ahead by Nordea
- Nordea Bank - No Rating: On the road towards above 13% ROE by Nordea
- SKF - Buy/SEK 274 (283): Inflation pain by Nordea
- Valmet - Buy/EUR 38 (38.70): Q4 margin miss just a blip by Nordea
- Kone (Hold, TP: EUR58.00) - Guiding for earnings decline by DnB Markets
- Loomis (Buy, TP: SEK390.00) - In solid recovery mode by DnB Markets
- Kinnevik (Buy, TP: SEK320.00) - Trough in bearish sentiment by DnB Markets
- Bonava (Buy, TP: SEK105.00) - Volatile, but deep value by DnB Markets
- Borregaard (Buy, TP: NOK260.00) - Set for another solid year by DnB Markets
- Valmet (Buy, TP: EUR42.00) - Slightly light by DnB Markets
- Cargotec (Buy, TP: EUR56.00) - Mixed, but on the weaker side by DnB Markets
- Konecranes (Buy, TP: EUR46.00) - A beat on orders and earnings by DnB Markets
- NATURGY: 4Q’21 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADELL) by Sabadell
- ITC (ITC IN) by HSBC
- Talk the Talk, Walk the Walk by BNP Paribas Exane
- VRL Logistics (VRLL IN) by HSBC
- Husqvarna - Buy/SEK 155: Set for a good start to 2022 by Nordea
- INVEST SECURITIES - NEMETSCHEK : La valorisation a bien baissé mais reste élevée - NEUTRE vs VENTE, OC 77€ vs 90€ by Invest Securities
- INVEST SECURITIES - DASSAULT SYSTEMES : Prématuré de repasser à l'ACHAT - NEUTRE, OC 40€ vs 48€ by Invest Securities
- SANOFI: RDOS. 4T’21 (ANÁLISIS BANCO SABADELL) by Sabadell
- Kinnevik - More downside risk as listed peers deep dive: Sell by Danske Bank Equity Research
- Danske Bank - It’s all relative by Danske Bank Equity Research
- Arjo - Buy/SEK 125 (130): Outlook for 2022 is not too bad by Nordea
- Axfood - Hold (Sell/SEK 180): Strong defensive growth warrants upgrade by Nordea
- Danske Bank - Sell/DKK 105: Set up for another cost disappointment by Nordea
- Nokia - Buy/EUR 6.50: Out of the woods after a successful 2021 by Nordea
- Nordic Semiconductor - Buy/NOK 375: Backlog reaching new highs by Nordea
- Scatec - Buy/NOK 175 (200): Valuation entering the no-growth zone by Nordea
- Novo Nordisk (Buy, TP: DKK780.00) - Wegovy key for 2022 guidance by DnB Markets
- Husqvarna (Hold, TP: SEK130.00) - Increased risk to 2022 estimates by DnB Markets
- Europris (Buy, TP: NOK73.00) - A record year and a record finish by DnB Markets
- Nordea (Buy, TP: SEK133.00) - All set to level up by DnB Markets
- Nordnet (Buy, TP: SEK200.00) - by DnB Markets
- Betsson (Buy, TP: SEK70.00) - The windmills will spin again by DnB Markets
- Arjo (Buy, TP: SEK125.00) - Q4 a bit weaker than expected by DnB Markets
- BioArctic (Buy, TP: SEK250.00) - Lecanemab in pole position by DnB Markets
- Danske Bank (Buy, TP: DKK145.00) - Encouraging revenue trends by DnB Markets
- Stronger? by BNP Paribas Exane